Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPlanchard, D ; Popat, S ; Kerr, K ; Novello, S ; Smit, E F ; Faivre-Finn, C ; Mok, T S ; Reck, M ; Van Schil, P E ; Hellmann, M D ; Peters, SAnnals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
2 |
Material Type: Artigo
|
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPeters, S ; Adjei, A A ; Gridelli, C ; Reck, M ; Kerr, K ; Felip, EAnnals of oncology, 2012-10, Vol.23 Suppl 7, p.vii56-vii64 [Periódico revisado por pares]EnglandTexto completo disponível |
|
3 |
Material Type: Artigo
|
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPopat, S. ; Baas, P. ; Faivre-Finn, C. ; Girard, N. ; Nicholson, A.G. ; Nowak, A.K. ; Opitz, I. ; Scherpereel, A. ; Reck, M.Annals of oncology, 2022-02, Vol.33 (2), p.129-142 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331Spigel, D.R. ; Vicente, D. ; Ciuleanu, T.E. ; Gettinger, S. ; Peters, S. ; Horn, L. ; Audigier-Valette, C. ; Pardo Aranda, N. ; Juan-Vidal, O. ; Cheng, Y. ; Zhang, H. ; Shi, M. ; Luft, A. ; Wolf, J. ; Antonia, S. ; Nakagawa, K. ; Fairchild, J. ; Baudelet, C. ; Pandya, D. ; Doshi, P. ; Chang, H. ; Reck, M.Annals of oncology, 2021-05, Vol.32 (5), p.631-641 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upDingemans, A.-M.C. ; Früh, M. ; Ardizzoni, A. ; Besse, B. ; Faivre-Finn, C. ; Hendriks, L.E. ; Lantuejoul, S. ; Peters, S. ; Reguart, N. ; Rudin, C.M. ; De Ruysscher, D. ; Van Schil, P.E. ; Vansteenkiste, J. ; Reck, M.Annals of oncology, 2021-07, Vol.32 (7), p.839-853 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189Rodríguez-Abreu, D. ; Powell, S.F. ; Hochmair, M.J. ; Gadgeel, S. ; Esteban, E. ; Felip, E. ; Speranza, G. ; De Angelis, F. ; Dómine, M. ; Cheng, S.Y. ; Bischoff, H.G. ; Peled, N. ; Reck, M. ; Hui, R. ; Garon, E.B. ; Boyer, M. ; Kurata, T. ; Yang, J. ; Pietanza, M.C. ; Souza, F. ; Garassino, M.C.Annals of oncology, 2021-07, Vol.32 (7), p.881-895 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPlanchard, D ; Popat, S ; Kerr, K ; Novello, S ; Smit, E F ; Faivre-Finn, C ; Mok, T S ; Reck, M ; Van Schil, P E ; Hellmann, M D ; Peters, SAnnals of oncology, 2019-05, Vol.30 (5), p.863-870 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
8 |
Material Type: Artigo
|
Small cell lung cancer: a slightly less orphan disease after immunotherapyRemon, J. ; Aldea, M. ; Besse, B. ; Planchard, D. ; Reck, M. ; Giaccone, G. ; Soria, J.-C.Annals of oncology, 2021-06, Vol.32 (6), p.698-709 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerSoria, J.-C. ; Mauguen, A. ; Reck, M. ; Sandler, A.B. ; Saijo, N. ; Johnson, D.H. ; Burcoveanu, D. ; Fukuoka, M. ; Besse, B. ; Pignon, J.-P.Annals of oncology, 2013-01, Vol.24 (1), p.20-30 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialMansfield, A.S. ; Każarnowicz, A. ; Karaseva, N. ; Sánchez, A. ; De Boer, R. ; Andric, Z. ; Reck, M. ; Atagi, S. ; Lee, J.-S. ; Garassino, M. ; Liu, S.V. ; Horn, L. ; Wen, X. ; Quach, C. ; Yu, W. ; Kabbinavar, F. ; Lam, S. ; Morris, S. ; Califano, R.Annals of oncology, 2020-02, Vol.31 (2), p.310-317 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |